Table 2.
Association between ER/PR/HER2 defined groups and Indigenous American genetic ancestry (for every 10% increase)
Covariates | Subtype | N | OR | 95% CI | P-value |
---|---|---|---|---|---|
By HER2 status | |||||
Univariate | HER2− | 837 | Ref. | ||
HER2+ | 392 | 1.10 | 1.02–1.19 | 0.012 | |
Age dx + Afr + Height | HER2− | 688 | Ref. | ||
HER2+ | 335 | 1.19 | 1.06–1.33 | 0.002 | |
Age dx + Afr + Height + rs140068132 | HER2− | 688 | Ref. | ||
HER2+ | 335 | 1.20 | 1.07–1.35 | 0.001 | |
By ER/PR/HER2 status | |||||
Univariate | ER/PR+ HER2− | 638 | Ref. | ||
ER/PR- HER2+ | 156 | 1.22 | 1.08–1.37 | 0.001 | |
ER/PR+ HER2+ | 239 | 1.06 | 0.97–1.16 | 0.175 | |
ER/PR/HER2− | 200 | 1.07 | 0.97–1.18 | 0.165 | |
Age dx + Afr + Height | ER/PR+ HER2− | 531 | Ref. | ||
ER/PR- HER2+ | 129 | 1.30 | 1.08–1.55 | 0.004 | |
ER/PR+ HER2+ | 209 | 1.17 | 1.02–1.33 | 0.024 | |
ER/PR/HER2− | 158 | 1.10 | 0.95–1.27 | 0.196 | |
Age dx + Afr + Height + rs140068132 | ER/PR+ HER2− | 531 | Ref. | ||
ER/PR- HER2+ | 129 | 1.32 | 1.10–1.57 | 0.002 | |
ER/PR+ HER2+ | 209 | 1.18 | 1.03–1.35 | 0.014 | |
ER/PR/HER2− | 158 | 1.11 | 0.96–1.29 | 0.141 |
Age dx: age at diagnosis; Afr: African genetic ancestry proportion